Investigating the role of angiopoietins in cardiac surgery outcomes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines the relationship between angiopoietin levels and adverse outcomes in patients undergoing cardiac surgery with cardiopulmonary bypass. It focuses on how dysregulation of angiopoietin 1 and 2 may indicate endothelial injury and systemic organ failure. By analyzing blood samples from adult patients scheduled for cardiac surgery, the researchers aim to identify potential biomarkers for predicting complications such as acute kidney injury. The findings could enhance understanding of the inflammatory processes involved in cardiac surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* adult patient scheduled for cardiac surgery under cardiopulmonary bypass

Exclusion Criteria:

* patient less than 18 years old,
* redo surgery,
* urgent surgery,
* endocarditis,
* aortic root repair surgery
* aortic dissection
* heart beating surgery,
* heart transplantation

Where it's running

• CHU Amiens Picardie
  Amiens, France Recruiting

Study contacts

• Study coordinator: Osama ABOU ARAB, MD
• Email: abouarab.osama@chu-amiens.fr
• Phone: 03 22 08 78 36

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Transcutaneous auricular vagus nerve stimulation to prevent kidney injury after heart surgery

  This trial tests whether applying a non-invasive ear stimulation (taVNS) around the time of elective heart surgery can help prevent acute kidney injury in adults undergoing cardiopulmonary bypass.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang · NCT07549243

• Guided fluid removal using VeXUS score for patients with acute kidney injury after heart surgery

  This study is testing if using the VeXUS score to manage fluid levels can help patients with acute kidney injury after heart surgery recover better than standard care.

  Recruiting Hospices Civils de Lyon · Bron, Bron and 1 other locations · NCT06251713

• Using LSALT peptide to prevent kidney injury in heart surgery patients

  This study is testing if a new peptide can help prevent kidney injury in patients having heart surgery.

  Recruiting at 4 sites Phase 2 Arch Biopartners Inc. · Calgary, Alberta and 8 other locations · NCT05879432

• Impact of Fast-Track Anesthesia on Postoperative Delirium After Cardiac Surgery

  This observational study tests whether fast-track anesthesia, compared with conventional care, is linked to lower rates of delirium after elective cardiac surgery in adults.

  Recruiting Second Affiliated Hospital of Nanchang University · Nanchang, Jiangxi · NCT07923344

• Sarcopenia in Patients After Cardiac Surgery

  This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07908472

• Remote Ischemic Preconditioning at Different Times After Heart Valve Surgery

  This study tests whether applying brief, controlled blood-flow restrictions to a limb at different times after heart valve surgery can help protect organs and reduce complications like kidney injury.

  Recruiting Fujian Medical University Union Hospital · Fuzhou, Fujian · NCT07888634

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.